Naltrexone (NTX) is a well-tolerated drug with a wide safety margin and mechanism of action that affords use across a wide variety of indications in adults and children. By antagonizing the opioid reward system, NTX can modulate behaviors that involve compulsivity or impulsivity, such as substance use, obesity, and eating disorders. Evidence regarding the disposition and efficacy of NTX is mainly derived from adult studies of substance use disorders and considerable variability exists. Developmental changes, plausible disease-specific alterations and genetic polymorphisms in NTX disposition, and pharmacodynamic pathways should be taken into consideration when optimizing the use of NTX in the pediatric population. This review highlights the current state of the evidence and gaps in knowledge regarding NTX to facilitate evidence-based pharmacotherapy of mental health conditions, for which few pharmacologic options exist.
Developmental Considerations for the Use of Naltrexone in Children and Adolescents
- Views Icon Views
- Share Icon Share
- Search Site
Stephani L. Stancil, Susan Abdel-Rahman, Jon Wagner; Developmental Considerations for the Use of Naltrexone in Children and Adolescents. The Journal of Pediatric Pharmacology and Therapeutics 1 November 2021; 26 (7): 675–695. doi: https://doi.org/10.5863/1551-6776-26.7.675
Download citation file: